LOC89944 Activators
LOC89944 Activators encompass a diverse range of chemical compounds that indirectly influence the activity of LOC89944 through multiple signaling pathways. Forskolin enhances LOC89944 activity by increasing cAMP levels, which in turn activates PKA, potentially phosphorylating substrates that interact with LOC89944. The PKC activator PMA might also enhance LOC89944 activity through PKC-mediated phosphorylation events. Ionomycin and A23187, as calcium ionophores, increase intracellular calcium, which activates calcium-dependent proteins and pathways that may engage LOC89944. Okadaic Acid, by inhibiting phosphatases PP1 and PP2A, maintains proteins in a phosphorylated state, which could positively affect LOC89944 signaling. Similarly, Anisomycin activates JNK and p38 MAPK, which could lead to the enhancement of LOC89944 activity by modifying signaling networks.
The functional activity of LOC89944 is further influenced by compounds that modulate kinase activity and lipid signaling. EGCG, a kinase inhibitor, and Genistein, a tyrosine kinase inhibitor, alter kinase-dependent pathways, potentially reducing competitive signaling and thereby enhancing LOC89944 activity. Thapsigargin, by inhibiting the SERCA pump, alters calcium homeostasis, which can indirectly lead to the activation of LOC89944-associated pathways. PI3K inhibitors LY294002 and Wortmannin disrupt AKT signaling, possibly impacting LOC89944 activity through changes in this pathway. Lastly, Sphingosine-1-phosphate acts through S1P receptors toexecute various downstream effects that can modify cellular processes, including those that may enhance the function of LOC89944. Collectively, these activators employ distinct mechanisms to influence cellular signaling cascades, resulting in the indirect enhancement of LOC89944's functional activity without the need for direct binding or upregulation of its expression.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol (DAG) analog which activates protein kinase C (PKC). PKC activation can phosphorylate substrates and alter signaling pathways that may enhance the activity of LOC89944. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent proteins and enzymes that can modulate signaling pathways. This increase in calcium signaling could indirectly enhance the activity of LOC89944. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of various proteins. This can alter signaling cascades and potentially increase the functional activity of LOC89944. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea with kinase inhibition properties. It can modulate signaling pathways by inhibiting kinases that may be upstream regulators of LOC89944, thus enhancing its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of stress-activated protein kinases such as JNK and p38 MAPK. Activation of these kinases can lead to changes in cellular signaling that enhance the activity of LOC89944. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways and potentially enhance the functional activity of LOC89944. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor which leads to an increase in cytosolic calcium levels. The resulting alteration in calcium signaling may indirectly enhance the activity of LOC89944. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to altered signaling through the AKT pathway, potentially affecting proteins and enzymes that interact with or modify LOC89944, thus enhancing its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that disrupts AKT signaling. This can lead to changes in cellular processes and indirect activation of LOC89944. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can modulate various signaling pathways, potentially enhancing the functional activity of LOC89944 by reducing competitive signaling. | ||||||